A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Atropine Injection,

Anticholinergic class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2018-07-09
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible
What is Atropine Injection, used for?

Atropine Injection, is a Anticholinergic medication tracked in Medicare Part D.

Is there a generic for Atropine Injection,?

No. Atropine Injection, is brand-only with no generic equivalents currently in market.

How much does my plan pay for Atropine Injection,?

NADAC pricing data not currently available for this drug.

Is Atropine Injection, on the FDA shortage list?

No. Atropine Injection, is not currently on the FDA Drug Shortage Database.

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anticholinergic6 alternatives in D1
01
Atropine
Brand: ATROPEN Auto-Injector
$4.33Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Atropine Sulfate Injection Usp,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Benztropine
Anticholinergic
$0.067Lowest NADAC
12Generic mfrs
$35.4MCY24 Part D spend
Compare →
04
Glycopyrrolate
Brand: Cuvposa
$0.103Lowest NADAC
35Generic mfrs
$15.4MCY24 Part D spend
Compare →
05
Ipratropium
Brand: Atrovent
$0.099Lowest NADAC
10Generic mfrs
$244.7MCY24 Part D spend
Compare →
06
Ipratropium and Albuterol
Brand: Combivent Respimat
$0.084Lowest NADAC
4Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.